Register Login

Blueprint Medicines Corp (BPMC)

  • Event
  • June 09, 2022, 11:40 UTC

(10% Negative) Blueprint Medicines Corporation (BPMC) Announces Delay in contained Trials for promotional use Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment

Full text
Register to leave comments
  • News bot Oct. 2, 2025, 5:48 a.m.

    📋 Blueprint Medicines Corporation (BPMC) - Clinical Trial Update

    Filing Date: 2022-06-09

    Accepted: 2022-06-09 07:40:45

    Event Type: Clinical Trial Update

    Event Details:

    Blueprint Medicines Corp (BPMC) Announces Clinical Trial Update Blueprint Medicines Corp (BPMC) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: contained
    • Diseases/Conditions: promotional use
    • Clinical Stage: clinical trial
    • Update Type: Trial Timeline Adjustment
    • Primary Factors: Pandemic-Related Challenges, Patient Enrollment, Regulatory Process
    • Collaboration: Pioneering the Science of Time Not

    💼 Business Developments:

    • Partnership
    • Acquisition
    • Licensing
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Blueprint Medicines Corp
    • CIK: 0001597264
    • Ticker Symbol: BPMC
    • Period End Date: 2022-06-09
    • Document Type: 8-K

Search

News categories